Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Baldelli · SciRah

Researcher profile · Semantic Scholar

A. Baldelli

Share profile

A. Baldelli — researcher profile on SciRah

h-index: 22
Works: 70
Citations: 2,033

Most-cited papers

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial.
S. Cascinu, V. Catalano, L. Cordella, R. Labianca +5 more
2002Journal of Clinical Oncology395 citations
Semantic Scholar
Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.
S. Cascinu, M. P. Staccioli, G. Gasparini, P. Giordani +8 more
2000Clinical Cancer Research221 citations
Semantic Scholar
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
V. Catalano, F. Loupakis, F. Graziano, U. Torresi +12 more
2009British Journal of Cancer199 citations Open access
Semantic Scholar
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients
F. Graziano, R. Bisonni, V. Catalano, R. Silva +9 more
2002British Journal of Cancer120 citations Open access
Semantic Scholar
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
V. Catalano, F. Graziano, D. Santini, S. D’Emidio +8 more
2008British Journal of Cancer108 citations Open access
Semantic Scholar
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.
V. Catalano, F. Loupakis, F. Graziano, R. Bisonni +16 more
2012Annals of Oncology95 citations Open access
Semantic Scholar
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer.
F. Graziano, V. Catalano, A. Baldelli, P. Giordani +5 more
2000Annals of Oncology89 citations Open access
Semantic Scholar
A systematic review of the role of pulmonary irradiation in the management of primary bone tumours.
J. Whelan, R. Burcombe, J. Janinis, A. Baldelli +1 more
2002Annals of Oncology80 citations Open access
Semantic Scholar
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).
S. Cascinu, Francesco Graziano, F. Ferraù, V. Catalano +17 more
2002Annals of Oncology57 citations Open access
Semantic Scholar
An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation
S. Cascinu, F. Graziano, V. Catalano, Maria Pia Staccioli +7 more
2002British Journal of Cancer53 citations Open access
Semantic Scholar
Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy.
S. Cascinu, F. Graziano, M. Valentini, V. Catalano +7 more
2001Annals of Oncology51 citations Open access
Semantic Scholar
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer
S. Cascinu, F. Graziano, S. Barni, R. Labianca +6 more
2001British Journal of Cancer44 citations Open access
Semantic Scholar
A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases
V. Catalano, R. Bisonni, F. Graziano, P. Giordani +8 more
2013Gastric Cancer43 citations Open access
Semantic Scholar
Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
D. Rossi, P. Alessandroni, V. Catalano, P. Giordani +6 more
2007Clinical Breast Cancer36 citations
Semantic Scholar
Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors
S. Cascinu, F. Graziano, V. Catalano, M. P. Staccioli +7 more
2004Clinical and Experimental Metastasis36 citations
Semantic Scholar
Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer
D. Rossi, A. Baldelli, V. Casadei, S. Fedeli +6 more
2008Anti-Cancer Drugs35 citations
Semantic Scholar
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
Daniele Santini, F. Graziano, V. Catalano, M. di Seri +11 more
2006BMC Cancer33 citations Open access
Semantic Scholar
HtrA1, a potential predictor of response to cisplatin‐based combination chemotherapy in gastric cancer
V. Catalano, P. Mellone, Alfredo d'Avino, V. Shridhar +14 more
2011Histopathology26 citations
Semantic Scholar
Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
D. Rossi, Donatella Dennetta, M. Ugolini, P. Alessandroni +7 more
2008Clinical Lung Cancer25 citations
Semantic Scholar
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer
F. Graziano, S. Cascinu, M. P. Staccioli, V. Catalano +5 more
2001BMC Cancer23 citations Open access
Semantic Scholar
Liver metastases from colorectal cancer.
S. Cascinu, Vincenzo Catalano, M. Scartozzi, A. Baldelli +1 more
1997Annals of Oncology23 citations Open access
Semantic Scholar
Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination.
S. Cascinu, V. Catalano, C. Aschele, S. Barni +9 more
2000Annals of Oncology22 citations Open access
Semantic Scholar
Molecular markers predictive of response to chemotherapy in gastrointestinal tumors.
V. Catalano, A. Baldelli, P. Giordani, S. Cascinu
2001Critical reviews in oncology/hematology21 citations
Semantic Scholar
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.
V. Catalano, F. Loupakis, F. Graziano, R. Bisonni +16 more
201220 citations Open access
Semantic Scholar
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer : A low cost effective regimen
S. Cascinu, A. Baldelli, V. Catalano, P. Giordani +11 more
2002British Journal of Cancer17 citations Open access
Semantic Scholar
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
M. Cazzaniga, I. Vallini, E. Montagna, D. Amoroso +45 more
2021Breast Cancer Research and Treatment16 citations Open access
Semantic Scholar
Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial
D. Rossi, Donatella Dennetta, M. Ugolini, V. Catalano +6 more
2010Targeted oncology16 citations
Semantic Scholar
Vascular Endothelial Growth Factor and p53 Expressions in Liver and Abdominal Metastases from Colon Cancer
S. Cascinu, F. Graziano, V. Catalano, S. Barni +8 more
2003Tumor Biology16 citations
Semantic Scholar
A phase II study of single-agent oral vinorelbine in patients with pretreated advanced non-small-cell lung cancer.
D. Rossi, V. Catalano, P. Alessandroni, A. Fedeli +8 more
2007Clinical Lung Cancer15 citations
Semantic Scholar
Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients
M. Scartozzi, Eva Galizia, Francesco Graziano, V. Catalano +6 more
2005British Journal of Cancer15 citations Open access
Semantic Scholar
Locoregional treatments of unresectable liver metastases from colorectal cancer.
S. Cascinu, Vincenzo Catalano, A. Baldelli, M. Scartozzi +3 more
1998Cancer Treatment Reviews14 citations
Semantic Scholar
The Value of Oxaliplatin in Combination with Continuous infusion ± Bolus 5-Fluorouracil and Levo-Folinic Acid in Metastatic Colorectal Cancer Progressing after 5FU-Based Chemotherapy: A Giscad (Italian Group for the Study of Digestive Tract) Cancer Phase II Trial
S. Mosconi, S. Cascinu, A. Zaniboni, V. Catalano +8 more
2000Tumori13 citations
Semantic Scholar
Gastrointestinal Cancer Refractory to Chemotherapy: A Role for Octreotide?
S. Cascinu, V. Catalano, P. Giordani, A. Baldelli +2 more
2001Chemotherapy10 citations
Semantic Scholar
Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy
F. Graziano, V. Catalano, A. Baldelli, S. Cascinu
2001Expert Review of Anticancer Therapy9 citations
Semantic Scholar
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First‐Line Exemestane: Results From a Prospective Study
S. Gagno, M. D'Andrea, M. Mansutti, Chiara Zanusso +36 more
2019Clinical Breast Cancer8 citations Open access
Semantic Scholar
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients
B. Trevisan, F. Pepe, I. Vallini, E. Montagna +42 more
2023Scientific Reports6 citations Open access
Semantic Scholar
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer.
S. Cascinu, R. Silva, R. Labianca, S. Barni +9 more
1999Annals of Oncology6 citations Open access
Semantic Scholar
Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy.
S. Cascinu, Francesco Graziano, V. Catalano, M. Valentini +6 more
2000Anticancer Research3 citations
Semantic Scholar
Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted
D. Rossi, P. Lippe, M. Rocchi, D. Sarti +11 more
2020In Vivo2 citations Open access
Semantic Scholar
Prognostic factors in metastatic gastric cancer patients (pts) treated with second-line chemotherapy
V. Catalano, F. Graziano, D. Santini, A. Baldelli +6 more
20162 citations
Semantic Scholar
Integrated production of liquid sulphur dioxide and sulphuric acid via a low-temperature cryogenic process
M. Verri, A. Baldelli
20132 citations
Semantic Scholar
Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study
V. Catalano, B. Vincenzi, P. Giordani, F. Graziano +10 more
2012Gastric Cancer2 citations Open access
Semantic Scholar
Neuroprotective effect of glutathione (GSH) on oxaliplatin (L-OHP)-based chemotherapy in advanced colorectal cancer patients (pts): a randomized double-blind placebo-controlled trial
V. Catalano, S. Cascinu, R. Labianca, P. Giordani +6 more
20012 citations
Semantic Scholar
The preliminary thermo–mechanical design, simulation and optimization, of LAD onboard the eXTP space mission
G. Lombardi, A. Baldelli, R. Fiacco, E. Lombardi +2 more
2023IOP Conference Series: Materials Science and Engineering1 citations Open access
Semantic Scholar
Patients with Locally Advanced Breast Cancer Receiving Intra-arterial Induction Chemotherapy: Report of a Phase II Clinical Study
G. Fiorentini, C. Aliberti, P. Coschiera, V. Casadei +4 more
20161 citations
Semantic Scholar
P-0068 The 7th Edition of the TNM Classification for Gastric Cancer and a Proposal of a New Classification for D2 Gastrectomy
V. Catalano, V. Sisti, D. Spada, F. Graziano +11 more
20121 citations Open access
Semantic Scholar
Assessment of the 7th edition of the AJCC classification and a proposal of a new classification in patients with gastric cancer undergoing D2 gastrectomy.
V. Catalano, V. Sisti, D. Spada, F. Graziano +12 more
20121 citations
Semantic Scholar
HtrA1 expression as a predictive factor of response to cisplatin-based regimen in patients with advanced gastric cancer.
V. Catalano, A. Baldi, V. Shridhar, Maria Pia Staccioli +7 more
2006Journal of Clinical Oncology1 citations
Semantic Scholar
Thymidylate synthase (TS) protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil (5FU)
S. Cascinu, C. Aschele, S. Barni, D. Debernardis +6 more
19991 citations
Semantic Scholar
An evaluation of potential neuroprotective effect of reduced-glutathione (GSH) on oxaliplatin (OXA) based chemotherapy in advanced colorectal cancer patients
V. Catalano, P. Giordani, A. Baldelli, L. Cordella +2 more
19991 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Catalano×41
Invite
V. Catalano — researcher profile on SciRah
P. Giordani×35
Invite
P. Giordani — researcher profile on SciRah
F. Graziano×25
Invite
F. Graziano — researcher profile on SciRah
G. Catalano×24
Invite
G. Catalano — researcher profile on SciRah

×18

Invite

D. Rossi — researcher profile on SciRah

P. Alessandroni×15

Invite

P. Alessandroni — researcher profile on SciRah

Invite

S. Cascinu — researcher profile on SciRah

Invite

S. Fedeli — researcher profile on SciRah

Invite

V. Casadei — researcher profile on SciRah

Invite

S. Cascinu — researcher profile on SciRah

Invite

R. Silva — researcher profile on SciRah

Invite

E. Testa — researcher profile on SciRah